New Publication in AMGA Group Practice Journal: The Information Advantage with CareSignal


In 2020, Epharmix rebranded to CareSignal. References to Epharmix and Epx are outdated.

Top accelerator Dreamit Health selects Epharmix to join its latest cohort

December 12, 2017 at 4:00 PM

Independence Blue CrossTop health accelerator, Dreamit Health recently selected Epharmix and six additional new companies to join its 2018 cohort. The new companies have developed innovative technology solutions ranging from remote patient monitoring and big data analytics to virtual reality and clinical decision tools in order to solve healthcare's most pressing challenges.

Based in Philadelphia, Dreamit Health is one of the top accelerators in the country, providing Epharmix and other new companies with valuable resources, including mentoring and strategic networking opportunities in the East Coast market. Dreamit distinguishes itself from other accelerators by offering unique introductions. Dreamit's connections to large enterprise accounts with strategic investment arms mean that partners have the potential to become both paying clients and investors.

The program kicked-off with an intensive two-week program of expert coaching and "Shark-Tank" style sales pitches. One such pitch was hosted by Independence Blue-Cross, one of the largest health insurers in Pennsylvania. Our EVP of Sales, Karen Hercules-Doerr, entered the Independence Blue Cross "Shark-Tank" to share how Epharmix helps risk-bearing organizations scale care management to address more patients, the "rising-risk" patients. She received great questions and insightful feedback from the panel.

The Epharmix team is looking forward to taking advantage of this great opportunity for networking, mentorship, and introductions to partners.